At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 232 enrolled
Drug / intervention
Glyceryl trinitrate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Double-blind, Placebo-controlled, Home Use, Cross-over Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
In Brief
A Phase 2 clinical trial evaluating Glyceryl trinitrate and MED Placebo for Erectile Dysfunction. Completed, enrolled 232 participants across 1 site.
Detailed Summary
This study is designed to evaluate the efficacy and safety of MED2005, a topically applied glyceryl trinitrate (GTN) gel administered to the penis of male subjects self-diagnosed with erectile dysfunction (ED) immediately before sexual intercourse.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesUnited Kingdom
CollaboratorsRichmond Pharmacology Limited
Timeline
Phase 2CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedJul 2015
Primary CompletionJul 2016
TodayJul 2026
First PostedJul 13, 2015
Enrollment StartMay 15, 2015
Primary CompletionJul 30, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.0 years ago
Interventions
Glyceryl trinitratedrug
At least 4 applications of MED2005 prior to intercourse over a period of 4 weeks
MED Placebodrug
At least 4 applications of MED2005 prior to intercourse over a period of 4 weeks